Drug Delivery Business

The top medtech stories of early 2017

By

Donald Trump top medtech stories
[Image courtesy of the White House]
The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry.

But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, diabetes treatment advances including promising study results for Insulet’s Omnipod Horizon hybrid closed-loop system, and much more.

Here are the top medical device stories of early 2017.

Next>>

(And check out Medical Design & Outsourcing’s April 11 webinar about the top medtech stories of early 2017.) 

IN CASE YOU MISSED IT

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.